335 related articles for article (PubMed ID: 8851566)
1. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.
Arts EJ; Wainberg MA
Antimicrob Agents Chemother; 1996 Mar; 40(3):527-40. PubMed ID: 8851566
[No Abstract] [Full Text] [Related]
2. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
[TBL] [Abstract][Full Text] [Related]
3. A novel anticancer agent ARC antagonizes HIV-1 and HCV.
Nekhai S; Bhat UG; Ammosova T; Radhakrishnan SK; Jerebtsova M; Niu X; Foster A; Layden TJ; Gartel AL
Oncogene; 2007 May; 26(26):3899-903. PubMed ID: 17173067
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside spiroxiranes as suicide inhibitors of the human immunodeficiency virus.
Bailey JM; Nelson KA
Biochem Soc Trans; 1995 Nov; 23(4):619S. PubMed ID: 8654804
[No Abstract] [Full Text] [Related]
5. Structure and biological activity correlation for some nucleoside analogues-inhibitors of reproduction of human immunodeficiency virus (HIV-1).
Gurskaya GV; Bochkarev AV; Tsapkina EN; Zdanov AS; Krayevsky AA
Nucleic Acids Symp Ser; 1991; (24):241. PubMed ID: 1841310
[No Abstract] [Full Text] [Related]
6. Lethal mutagenesis of HIV with mutagenic nucleoside analogs.
Loeb LA; Essigmann JM; Kazazi F; Zhang J; Rose KD; Mullins JI
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1492-7. PubMed ID: 9990051
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside drug resistance in HIV-1 reverse transcriptase.
Yadav PN; Yadav JS; Modak MJ
Nat Struct Biol; 1995 Mar; 2(3):193-5. PubMed ID: 7539709
[No Abstract] [Full Text] [Related]
8. Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype.
Van Laethem K; Witvrouw M; Pannecouque C; Van Remoortel B; Schmit JC; Esnouf R; Kleim JP; Balzarini J; Desmyter J; De Clercq E; Vandamme AM
AIDS; 2001 Mar; 15(5):553-61. PubMed ID: 11316991
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside analogues previously found to be inactive against HIV may be activated by simple chemical phosphorylation.
McGuigan C; Kinchington D; Wang MF; Nicholls SR; Nickson C; Galpin S; Jeffries DJ; O'Connor TJ
FEBS Lett; 1993 May; 322(3):249-52. PubMed ID: 8387430
[TBL] [Abstract][Full Text] [Related]
10. Anti-HIV activity of new substituted 1,3,4-oxadiazole derivatives and their acyclic nucleoside analogues.
El-Sayed WA; El-Essawy FA; Ali OM; Nasr BS; Abdalla MM; Abdel-Rahman AA
Z Naturforsch C J Biosci; 2009; 64(11-12):773-8. PubMed ID: 20158144
[TBL] [Abstract][Full Text] [Related]
11. L-Nucleosides as chemotherapeutic agents.
Gumina G; Song GY; Chu CK
FEMS Microbiol Lett; 2001 Aug; 202(1):9-15. PubMed ID: 11506901
[TBL] [Abstract][Full Text] [Related]
12. The nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitors.
Kew Y; Salomon H; Olsen LR; Wainberg MA; Prasad VR
Antimicrob Agents Chemother; 1996 Jul; 40(7):1711-4. PubMed ID: 8807067
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of HIV-1 transcription.
Li CJ; Dezube BJ; Biswas DK; Ahlers CM; Pardee AB
Trends Microbiol; 1994 May; 2(5):164-9. PubMed ID: 8055180
[TBL] [Abstract][Full Text] [Related]
14. Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.
Bridges EG; Dutschman GE; Gullen EA; Cheng YC
Biochem Pharmacol; 1996 Mar; 51(6):731-6. PubMed ID: 8602867
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs.
Ratner L; Vander Heyden N
AIDS Res Hum Retroviruses; 1993 Apr; 9(4):291-7. PubMed ID: 8390276
[TBL] [Abstract][Full Text] [Related]
16. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
Chen YL; Yokokawa F; Shi PY
Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
[TBL] [Abstract][Full Text] [Related]
17. Correlation of molecular conformation and activity of reverse transcriptase inhibitors.
Van Roey P; Taylor EW; Chu CK; Schinazi RF
Ann N Y Acad Sci; 1990; 616():29-40. PubMed ID: 1706572
[No Abstract] [Full Text] [Related]
18. HIV-1 and HSV-1 virus activities of some new polycyclic nucleoside pyrene candidates.
Khalifa NM; Al-Omar MA; Amr Ael-G; Haiba ME
Int J Biol Macromol; 2013 Mar; 54():51-6. PubMed ID: 23178400
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.
Choo H; Beadle JR; Kern ER; Prichard MN; Keith KA; Hartline CB; Trahan J; Aldern KA; Korba BE; Hostetler KY
Antimicrob Agents Chemother; 2007 Feb; 51(2):611-5. PubMed ID: 17130297
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates.
Rezende LF; Prasad VR
Int J Biochem Cell Biol; 2004 Sep; 36(9):1716-34. PubMed ID: 15183340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
